Does improving mood in depressed patients alter factors that may affect cardiovascular disease risk?

Journal of Psychiatric Research

Volumn 43, Issue 16, 2009, Pages 1246-1252

  Taylor, C Barr ^a   Conrad, Ansgar ^a,b   Wilhelm, Frank H ^c   Strachowski, Diane ^a   Khaylis, Anna ^a   Neri, Eric ^a   Giese Davis, Janine ^a   Roth, Walton T ^a,b   Cooke, John P ^a   Kraemer, Helena ^a   Spiegel, David ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Cognitive behavioral therapy; CVD; Depression; Risk factors

Indexed keywords

C REACTIVE PROTEIN; HYDROCORTISONE; LIPID; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HEART RATE; HOSPITAL ADMISSION; HUMAN; MALE; MOOD; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SALIVA LEVEL; SCORING SYSTEM;

AFFECT; AGED; AREA UNDER CURVE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COGNITIVE THERAPY; DEPRESSION; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SALIVA; STRESS, PSYCHOLOGICAL;

EID: 70449526525     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2009.05.006     Document Type: Article

References (38)

1. Aromaa A., Raitasalo R., Reunanen A., Impivaara O., Heliovaara M., Knekt P., et al. Depression and cardiovascular diseases. Acta Psychiatric Scandinavica 77 (1994) 77-78
2. Bar K.J., Greiner W., Jochum T., Friedrich M., Wagner G., and Sauer H. The influence of major depression and its treatment on heart rate variability and pupillary light reflex parameters. Journal of Affective Disorders 82 2 (2004) 245-252
3. Berkman L.F., Blumenthal J., Burg M., Carney R.M., Catellier D., Cowan M.J., et al. Enhancing recovery in coronary heart disease patients investigators (ENRICHD). Effects of treating depression and low recovery in coronary heart disease patients (ENRICHD) randomized trial. JAMA 289 23 (2003) 3106-3116
4. Brown E.S., Varghese F.P., and McEwen B.S. Association of depression with medical illness: does cortisol play a role?. Biological Psychiatry 55 1 (2004) 1-9
5. Burke H.M., Davis M.C., Ottec C., and Mohr D.C. Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology 30 9 (2005) 846-856
6. Burke H.M., Fernald L.C., Gertler P.J., and Adler N.E. Depressive symptoms are associated with blunted cortisol stress responses in very low-income women. Psychosomatic Medicine 67 2 (2005) 211-216
7. Carney R.M., Freedland K.E., and Sheps D. Depression is a risk factor for mortality in coronary heart disease. Psychosomatic Medicine 66 6 (2004) 799-801
8. Carney R.M., Freedland K.E., Stein P.K., Skala J.A., Hoffman P., and Jaffe A.S. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosomatic Medicine 62 (2000) 639-647
9. Carney R.M., Freedland K.E., and Veith R.C. Depression, the autonomic nervous system, and coronary heart disease. Psychosomatic Medicine 67 Suppl. 1 (2005) S29-S33
10. Dalack G.W., and Roose S.P. Perspectives on the relationship between cardiovascular disease and affective disorder. Journal of Clinical Psychiatry 51 Suppl. (1990) 4-9
11. DeRubeis R.J., Hollon S.D., Amsterdam J.D., Shelton R.C., Young P.R., Salomon R.M., et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Archives of General Psychiatry 62 4 (2005) 409-416
12. Deuschle M., Hamann B., Meichel C., Krumm B., Lederbogen F., Kniest A., et al. Antidepressive treatment with amitriptyline and paroxetine: effects on saliva cortisol concentrations. Journal of Clinical Psychopharmacology 23 2 (2003) 201-205
13. Dhabhar F.S., Miller A.H., McEwen B.S., and Spencer R.L. Stress-induced changes in blood leukocyte distribution. Role of adrenal steroid hormones. Journal of Immunology 157 4 (1996) 1638-1644
14. Frasure-Smith N., Lesperance F., and Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 91 4 (1995) 999-1005
15. Freedland K.E., Skala J.A., Carney R.M., Raczynski J.M., Taylor C.B., Mendes de Leon C.F., et al. The depression interview and structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. Psychosomatic Medicine 64 6 (2002) 897-905
16. Gloaguen V., Cottraux J., Cucherat M., and Blackburn I. A meta-analysis of the effects of cognitive therapy in depressed patients. Journal of Affective Disorders 49 (1998) 59-72
17. Gold P.W., and Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Molecular Psychiatry 7 3 (2002) 254-275
18. Howren M.B., Lamkin D.M., and Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine 71 2 (2009) 171-186
19. Katona P.G., and Jih F. Respiratory sinus arrhythmia: noninvasive measure of the parasympathetic cardiac control. Journal of Applied Physiology 39 (1975) 801-805
20. Kirschbaum C., Pirke K.M., and Hellhammer D.H. The 'Trier Social Stress Test' - a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28 (1993) 76-81
21. Kleiger R.E., Miller P.J., Bigger T.J., Moss A.J., and Multicenter Post-Infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. American Journal of Cardiology 59 (1987) 256-262
22. Kraemer H.C., Stice E., Kazdin A., Offord D., and Kupfer D. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. American Journal of Psychiatry 158 6 (2001) 848-856
23. Kraemer H.C., and Blasey C.M. Centering in regression analyses: a strategy to prevent errors in statistical inference. International Journal of Methods in Psychiatric Research 13 (2004) 141-151
24. Licht C.M., de Geus E.J., Zitman F.G., Hoogendijk W.J., van Dyck R., and Penninx B.W. Association between major depressive disorder and heart rate variability in the Netherlands study of depression and anxiety (NESDA). Archives of General Psychiatry 65 12 (2008) 1358-1367
25. Linkowski P., Mendlewicz J., Kerkhofs M., Leclercq R., Golstein J., Brasseur M., et al. 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. Journal of Clinical Endocrinology and Metabolism 65 1 (1987) 141-152
26. McLaughlin T., Abbasi F., Cheal K., Chu J., Lamendola C., and Reaven G.M. Use of metabolic markers to identify overweight individuals who are insulin resistant. Annals of Internal Medicine 139 (2003) 802-809
27. Miller G.E., Rohleder N., Stetler C., and Kirshbaum C. Clinical depression and regulation of the inflammatory response during acute stress. Psychosomatic Medicine 67 (2005) 679-687
28. Moreno P.R. The year in atherothrombosis. JACC 44 (2004) 2099-2110
29. Musselman D.L., Evans D.L., and Nemeroff C.B. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Archives of General Psychiatry 55 7 (1998) 580-592
30. Nemeroff C.B., and Owens M.J. Pharmacologic differences among the SSRIs: focus on monoamine transporters and the HPA axis. CNS Spectrum 9 6 Suppl. 4 (2004) 23-31
31. Pruessner J.D., Kirschbaum C., Meinlschmid G., and Hellhammer D.J. Two formulas for computation of area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28 (2003) 916-931
32. Rota E., Broda R., Cangemi L., Migliaretti G., Paccotti P., Rosso C., et al. Neuroendocrine (HPA axis) and clinical correlates during fluvoxamine and amitriptyline treatment. Psychiatry Research 133 2-3 (2005) 281-284
33. Stewart J.W., Quitkin F.M., McGrath P.J., and Klein D.F. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions. Journal of Affective Disorders 86 2-3 (2005) 161-167
34. Strachowski D., Khaylis A., Conrad A., Neri E., Spiegel D., and Taylor C.B. The effects of directed cognitive behavior therapy on depression in older patients with cardiovascular risk. Depression and Anxiety 25 8 (2008) E1-E10
35. Strike P.C., and Steptoe A. Systematic review of mental stress-induced myocardial ischaemia. European Heart Journal 24 (2003) 690-703
36. Taylor C.B., Conrad A., Wilhelm F.H., Neri E., Delorenzo A., Kramer M.A., et al. Psychophysiological and cortisol responses to psychological stress in depressed and non-depressed older men and women with elevated CVD risk. Psychosomatic Medicine 68 4 (2006) 538-546
37. Wilhelm F.H., Grossman P., and Coyle M.A. Improving estimation of cardiac vagal tone during spontaneous breathing using a paced breathing calibration. Biomedical Sciences Instrumentation 40 (2004) 317-324
38. Wilhelm F.H., Grossman P., and Roth W.T. Analysis of cardiovascular regulation. Biomedical Sciences Instrumentation 35 (1999) 135-140